EUVIMEDEUVIMED entdecken
Kommentar

In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiency

Gunjan Y Gandhi

Annals of Internal Medicine · 2023

DOI: 10.7326/j23-0013 ↗

Kurz gefasst

Kommentar in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Gunjan Y Gandhi. Beteiligte Einrichtung: University of Florida, Jacksonville, Florida, USA (G.Y.G.). Hauptthemen laut MEDLINE: Adenoma, Adrenal Insufficiency, Pituitary Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenomaAdrenal InsufficiencyPituitary NeoplasmsHumansGlucocorticoidsHydrocortisoneHypothalamo-Hypophyseal SystemRandomized Controlled Trials as Topic

Substanzen

GlucocorticoidsHydrocortisone

Autor:innen und Institutionen

  • University of Florida, Jacksonville, Florida, USA (G.Y.G.).

Zitieren

APA

Gandhi, G. Y. (2023). In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiency. Annals of Internal Medicine. https://doi.org/10.7326/j23-0013

Vancouver

Gandhi GY. In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiency. Annals of Internal Medicine. 2023. doi:10.7326/j23-0013

BibTeX
@article{Gandhi2023,
  author = {Gandhi, Gunjan Y},
  title = {In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiency},
  journal = {Annals of Internal Medicine},
  year = {2023},
  doi = {10.7326/j23-0013}
}
Kostenlos starten →